|
by Movik, Espen, Hamidi, Vida, Natvig Norderhaug, Inger, Klemp, Marianne
Published 2009
“... of bevacizumab+paclitaxel from a health service perspective to be NOK 765 000, which translates into a cost per...”Published 2009
Norwegian Knowledge Centre for the Health Services